SCHEMBL2848482

SCHEMBL2848482

c1ccc(-c2c3ccccc3c(-c3ccc4ccc5ccccc5c4c3)c3ccccc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
HSD17B10 Q99714 3/20 0.54
HIF1A Q16665 1/20 0.54
CYP1B1 Q16678 1/20 0.54
TDP1 Q9NUW8 2/20 0.50
CYP2A6 P11509 1/20 0.50
TSHR P16473 1/20 0.50
ESR1 P03372 5/20 0.47
ESR2 Q92731 5/20 0.47
HPRT1 P00492 3/20 0.46
ALOX5 P09917 1/20 0.44
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18880010 0.98 ALDH1A1 (0.52) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL25829126 0.96 ALDH1A1 (0.46) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL3786709 0.90 ALDH1A1 (0.48) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL18880009 0.88 ESR1 (0.51) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL25829686 0.88 ESR1 (0.41) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL2849156 0.88 ALDH1A1 (0.54) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL23242765 0.87 SOS1 (0.51) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL19200591 0.87 ALDH1A1 (0.45) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL19199245 0.86 ESR1 (0.50) ALDH1A1HSD17B10HIF1ACYP1B1TDP1
SCHEMBL13015753 0.86 ALDH1A1 (0.44) ALDH1A1HSD17B10HIF1ACYP1B1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200395553-A1 ORGANIC ELECTROLUMINESCENT DEVICE SFC CO., LTD. (KR) 2020-12-17 US disclosed
US-8993123-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-31 US disclosed
US-20100327270-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-12-30 US disclosed
EP-2240425-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2010-10-20 EP disclosed
WO-2009100925-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327270-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, ELAVL1, EPCAM ALDH1A1 336/4885HSD17B10 2767/4885HIF1A 3000/4885
US-20200395553-A1 ORGANIC ELECTROLUMINESCENT DEVICE LEF1, AP2A2, CCNA1 ALDH1A1 17/4885HSD17B10 1668/4885HIF1A 3434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.